Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...

Biotechnology and pharmaceutical organizations are increasingly viewing bioinformatics as an integral part of their research processes. They make use of vast amounts of genomic data and produce more ...

MANASSAS, Va.--(BUSINESS WIRE)--ATCC, the world’s premier biological materials management and standards organization, today announced that it has entered into an agreement with QIAGEN, a recognized ...

According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

In a recent study published in Viruses, researchers discuss an open-source and automated bioinformatics pipeline to prospectively and routinely analyze and integrate heterogeneous human ...

VENLO, The Netherlands & REDWOOD CITY, Calif.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the official opening of a new data center in Melbourne, Australia, ...

“The percentage of office actions issued by the business-method art units that included eligibility rejections increased to over 90% after Alice was issued. A near-identical increase in eligibility ...

Bioinformatics is rapidly changing the course of human health and history. Scientists and researchers use data like never before to save countless lives each day. Bioinformatics fuels new discoveries ...

Billions of dollars are flowing into computational biology. From working to find improved outcomes for health issues to better policy planning, it’s possible to find enormous value inside bio-data.

Bioinformatics is the process of analyzing, managing and storing biological data for the purpose of scientific development. Data includes genetic sequencing, human protein analysis and the modeling of ...